On October 10, 2025, the Centre for Human Drug Research (CHDR) will open its new clinical research unit at Medisch Spectrum Twente (MST). This will be CHDR’s second research location in the Netherlands, alongside its centre established in Leiden in 1987. The opening marks the next step in the collaboration between CHDR, MST, and the Technical Medical Centre of the University of Twente (UT).
The establishment of the CHDR Twente aligns with the ambition of all three partners to jointly further develop a vibrant medical technology research cluster in Twente, with a focus on therapeutic innovation. We contribute to the development of better medicines and treatments for patients, making an impact on the region.
About CHDR
For nearly 40 years, CHDR has been a leading independent organisation in clinical drug research. The institute has grown to over 300 employees and is located in the Leiden BioScience Park, between Leiden University and Leiden University Medical Centre, with which it maintains close collaborations.
With a view to further growth, CHDR sought expansion beyond the Randstad. The right partners were found in Twente: Medisch Spectrum Twente, a large STZ hospital, and the University of Twente with its TechMed Centre focused on medical technology, research, innovation, and technical medical education. Both institutions already collaborate and provide space for an independent clinical research department. Their ambitions are well aligned. In 2024, a cooperation agreement was signed, and the development of CHDR Twente began.
More recent news
Tue 31 Mar 2026Three open competition grants for health research
Mon 30 Mar 2026Minister Rianne Letschert visits Twente: education and science as drivers of the hospital of the future
Wed 25 Mar 20264TU.Health Event 2026 sets course for collaborative healthcare innovation
Tue 17 Mar 2026Researchers develop bionic foot that restores a natural walking pattern
Thu 12 Mar 2026Bernardus Thio appointed professor at UT